<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37144614</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>08</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1746-6318</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>01</Day></PubDate></JournalIssue><Title>Current opinion in HIV and AIDS</Title><ISOAbbreviation>Curr Opin HIV AIDS</ISOAbbreviation></Journal><ArticleTitle>Long COVID in people living with HIV.</ArticleTitle><Pagination><StartPage>126</StartPage><EndPage>134</EndPage><MedlinePgn>126-134</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/COH.0000000000000789</ELocationID><Abstract><AbstractText Label="PURPOSE OF REVIEW">It is now recognized that SARS-CoV-2 infection can have a long-term impact on health. This review summarizes the current state of knowledge regarding Long COVID in people living with HIV (PLWH).</AbstractText><AbstractText Label="RECENT FINDINGS">PLWH may be at elevated risk of experiencing Long COVID. Although the mechanisms contributing to Long COVID are incompletely understood, there are several demographic and clinical factors that might make PLWH vulnerable to developing Long COVID.</AbstractText><AbstractText Label="SUMMARY">PLWH should be aware that new or worsening symptoms following SARS-CoV-2 infection might represent Long COVID. HIV providers should be aware of this clinical entity and be mindful that their patients recovering from SARS-CoV-2 infection may be at higher risk.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Wolters Kluwer Health, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Peluso</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antar</LastName><ForeName>Annukka A R</ForeName><Initials>AAR</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K23 AI157875</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>L30 AI147159</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI158013</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AI167648</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Curr Opin HIV AIDS</MedlineTA><NlmUniqueID>101264945</NlmUniqueID><ISSNLinking>1746-630X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015658" MajorTopicYN="Y">HIV Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001364" MajorTopicYN="N">Awareness</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><i>Conflicts of interest</i>. MJP reports consulting fees from Gilead Sciences and AstraZeneca.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>8</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>5</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>5</Day><Hour>6</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37144614</ArticleId><ArticleId IdType="mid">NIHMS1880403</ArticleId><ArticleId IdType="pmc">PMC10167544</ArticleId><ArticleId IdType="doi">10.1097/COH.0000000000000789</ArticleId><ArticleId IdType="pii">01222929-202305000-00004</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Callard F, Perego E: How and why patients made Long Covid. Soc Sci Med 2021, 268:113426.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, Kim SS, Lindsell CJ, Billig Rose E, Shapiro NI, Files DC, Gibbs KW, Erickson HL, Steingrub JS, Smithline HA, et al.: Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network - United States, March-June 2020. MMWR Morb Mortal Wkly Rep 2020, 69:993&#x2013;998.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>NIH launches new initiative to study &#x201c;Long COVID.&#x201d; National Institutes of Health (NIH) 2021,</Citation></Reference><Reference><Citation>The White House: Memorandum on addressing the Long-Term Effects of COVID-19. The White House 2022,</Citation></Reference><Reference><Citation>Coronavirus: Coronavirus &#xbb; Long COVID: the NHS plan for 2021/22. [date unknown],</Citation></Reference><Reference><Citation>Baraniuk C: Covid-19: How Europe is approaching long covid. BMJ 2022, 376:o158.</Citation><ArticleIdList><ArticleId IdType="pubmed">35058230</ArticleId></ArticleIdList></Reference><Reference><Citation>Office of the Assistant Secretary for Health (OASH): Health+ long COVID. HHS.gov
2022,</Citation></Reference><Reference><Citation>Koroshetz Walter J., M. D., National Institute of Neurological Disorders and Stroke, Lawrence Tabak DDS, Collins F: PASC. NIH Director&#x2019;s Blog [date unknown],</Citation></Reference><Reference><Citation>Bowe B, Xie Y, Al-Aly Z: Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nat Med 2022, 28:2398&#x2013;2405.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9671810</ArticleId><ArticleId IdType="pubmed">36357676</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D, Sun A, Ssentongo AE, Ba DM, Parsons N, Poudel GR, Lekoubou A, Oh JS, Ericson JE, Ssentongo P, et al.: Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection: A Systematic Review. JAMA Netw Open 2021, 4:e2128568.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Gennaro F, Belati A, Tulone O, Diella L, Fiore Bavaro D, Bonica R, Genna V, Smith L, Trott M, Bruyere O, et al.: Incidence of long COVID-19 in people with previous SARS-Cov2 infection: a systematic review and meta-analysis of 120,970 patients. Intern Emerg Med 2022, doi:10.1007/s11739-022-03164-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-022-03164-w</ArticleId><ArticleId IdType="pmc">PMC9709360</ArticleId><ArticleId IdType="pubmed">36449260</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, Pujol JC, Klaser K, Antonelli M, Canas LS, et al.: Attributes and predictors of long COVID. Nat Med 2021, doi:10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A, Wamil M, Alberts J, Oben J, Cuthbertson DJ, Wootton D, Crooks M, Gabbay M, Brady M, Hishmeh L, et al.: Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open 2021, 11:e048391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Xie Y, Bowe B: High-dimensional characterization of post-acute sequelae of COVID-19. Nature 2021, 594:259&#x2013;264.</Citation><ArticleIdList><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Bowe B, Xie Y, Xu E: One-year risks and burdens of incident cardiovascular disease in COVID-19: Cardiovascular manifestations of long COVID. Research Square 2021, doi:10.21203/rs.3.rs-940278/v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-940278/v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Bowe B, Xie Y: Long COVID after breakthrough SARS-CoV-2 infection. Nat Med 2022,</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Choi T, Al-Aly Z: Nirmatrelvir and the Risk of Post-Acute Sequelae of COVID-19. [date unknown], doi:10.1101/2022.11.03.22281783.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.11.03.22281783</ArticleId></ArticleIdList></Reference><Reference><Citation>Yomogida K, Zhu S, Rubino F, Figueroa W, Balanji N, Holman E: Post-Acute Sequelae of SARS-CoV-2 Infection Among Adults Aged &#x2265;18 Years - Long Beach, California, April 1-December 10, 2020. MMWR Morb Mortal Wkly Rep 2021, 70:1274&#x2013;1277.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8445372</ArticleId><ArticleId IdType="pubmed">34529639</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen K, Ren S, Heath K, Dasmari&#xf1;as MC, Jubilo KG, Guo Y, Lipsitch M, Daugherty SE: Risk of persistent and new clinical sequelae among adults aged 65 years and older during the post-acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ 2022, 376:e068414.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8828141</ArticleId><ArticleId IdType="pubmed">35140117</ArticleId></ArticleIdList></Reference><Reference><Citation>Bull-Otterson L: Post&#x2013;COVID Conditions Among Adult COVID-19 Survivors Aged 18&#x2013;64 and &#x2265;65 Years &#x2014; United States, March 2020&#x2013;November 2021. MMWR Morb Mortal Wkly Rep 2022, 71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9368731</ArticleId><ArticleId IdType="pubmed">35925799</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlis RH, Santillana M, Ognyanova K, Safarpour A, Lunz Trujillo K, Simonson MD, Green J, Quintana A, Druckman J, Baum MA, et al.: Prevalence and Correlates of Long COVID Symptoms Among US Adults. JAMA Netw Open 2022, 5:e2238804.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9614581</ArticleId><ArticleId IdType="pubmed">36301542</ArticleId></ArticleIdList></Reference><Reference><Citation>Wanga V, Chevinsky JR, Dimitrov LV, Gerdes ME, Whitfield GP, Bonacci RA, Nji MAM, Hernandez-Romieu AC, Rogers-Brown JS, McLeod T, et al.: Long-Term Symptoms Among Adults Tested for SARS-CoV-2 - United States, January 2020-April 2021. MMWR Morb Mortal Wkly Rep 2021, 70:1235&#x2013;1241.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8437054</ArticleId><ArticleId IdType="pubmed">34499626</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez-Romieu AC, Leung S, Mbanya A, Jackson BR, Cope JR, Bushman D, Dixon M, Brown J, McLeod T, Saydah S, et al.: Health Care Utilization and Clinical Characteristics of Nonhospitalized Adults in an Integrated Health Care System 28&#x2013;180 Days After COVID-19 Diagnosis - Georgia, May 2020-March 2021. MMWR Morb Mortal Wkly Rep 2021, 70:644&#x2013;650.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8084119</ArticleId><ArticleId IdType="pubmed">33914727</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Bermingham C, Pouwels KB, Glickman M, Nafilyan V, Zaccardi F, Khunti K, Alwan NA, Walker AS: Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study. BMJ 2022, 377:e069676.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9115603</ArticleId><ArticleId IdType="pubmed">35584816</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D: Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK - Office for National Statistics. 2021,</Citation></Reference><Reference><Citation>Ayoubkhani D, Pawelek P, Gaughan C: Technical article: Updated estimates of the prevalence of post-acute symptoms among people with coronavirus (COVID-19) in the UK - Office for National Statistics. 2021,</Citation></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, Kang L, Guo L, Liu M, Zhou X, et al.: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 2021, 397:220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Roessler M, Tesch F, Batram M, Jacob J, Loser F, Weidinger O, Wende D, Vivirito A, Toepfner N, Seifert M, et al.: Post COVID-19 in children, adolescents, and adults: results of a matched cohort study including more than 150,000 individuals with COVID-19. bioRxiv 2021, doi:10.1101/2021.10.21.21265133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.10.21.21265133</ArticleId><ArticleId IdType="pmc">PMC9648706</ArticleId><ArticleId IdType="pubmed">36355754</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Luciano S, Geddes JR, Husain M, Harrison PJ: Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med 2021, 18:e1003773.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering AV, van Zon SKR, olde Hartman TC, Rosmalen JGM: Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet 2022, 400:452&#x2013;461.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B, Mohn KG-I, Brokstad KA, Zhou F, Linchausen DW, Hansen B-A, Lartey S, Onyango TB, Kuwelker K, S&#xe6;vik M, et al.: Long COVID in a prospective cohort of home-isolated patients. Nat Med 2021, doi:10.1038/s41591-021-01433-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01433-3</ArticleId><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Lund LC, Hallas J, Nielsen H, Koch A, Mogensen SH, Brun NC, Christiansen CF, Thomsen RW, Potteg&#xe5;rd A: Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a Danish population-based cohort study. Lancet Infect Dis 2021, 21:1373&#x2013;1382.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8110209</ArticleId><ArticleId IdType="pubmed">33984263</ArticleId></ArticleIdList></Reference><Reference><Citation>Morioka S, Tsuzuki S, Suzuki M, Terada M, Akashi M, Osanai Y, Kuge C, Sanada M, Tanaka K, Maruki T, et al.: Post COVID-19 condition of the Omicron variant of SARS-CoV-2. bioRxiv 2022, doi:10.1101/2022.05.12.22274990.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.05.12.22274990</ArticleId><ArticleId IdType="pmc">PMC9365517</ArticleId><ArticleId IdType="pubmed">35963600</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzolini E, Levi R, Sarti R, Pozzi C, Mollura M, Mantovani A, Rescigno M: Association Between BNT162b2 Vaccination and Long COVID After Infections Not Requiring Hospitalization in Health Care Workers. JAMA 2022, doi:10.1001/jama.2022.11691.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.11691</ArticleId><ArticleId IdType="pmc">PMC9250078</ArticleId><ArticleId IdType="pubmed">35796131</ArticleId></ArticleIdList></Reference><Reference><Citation>Boglione L, Meli G, Poletti F, Rostagno R, Moglia R, Cantone M, Esposito M, Scianguetta C, Domenicale B, Di Pasquale F, et al.: Risk factors and incidence of long-COVID syndrome in hospitalized patients: does remdesivir have a protective effect? QJM 2022, 114:865&#x2013;871.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8690187</ArticleId><ArticleId IdType="pubmed">34850210</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutler DM: The Costs of Long COVID. JAMA Health Forum 2022, 3:e221809&#x2013;e221809.</Citation><ArticleIdList><ArticleId IdType="pubmed">36219031</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, Cook JR, Nordvig AS, Shalev D, Sehrawat TS, et al.: Post-acute COVID-19 syndrome. Nat Med 2021, doi:10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Kelly JD, Lu S, Goldberg SA, Davidson MC, Mathur S, Durstenfeld MS, Spinelli MA, Hoh R, Tai V, et al.: Persistence, Magnitude, and Patterns of Postacute Symptoms and Quality of Life Following Onset of SARS-CoV-2 Infection: Cohort Description and Approaches for Measurement. Open Forum Infect Dis 2022, 9:ofab640.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8755302</ArticleId><ArticleId IdType="pubmed">35106317</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenny G, McCann K, O&#x2019;Brien C, Savinelli S, Tinago W, Yousif O, Lambert JS, O&#x2019;Broin C, Feeney ER, De Barra E, et al.: Identification of Distinct Long COVID Clinical Phenotypes Through Cluster Analysis of Self-Reported Symptoms. Open Forum Infect Dis 2022, 9:ofac060.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8900926</ArticleId><ArticleId IdType="pubmed">35265728</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Zang C, Xu Z, Zhang Y, Xu J, Bian J, Morozyuk D, Khullar D, Zhang Y, Nordvig AS, et al.: Data-driven identification of post-acute SARS-CoV-2 infection subphenotypes. Nat Med 2022, doi:10.1038/s41591-022-02116-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02116-3</ArticleId><ArticleId IdType="pmc">PMC9873564</ArticleId><ArticleId IdType="pubmed">36456834</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, Villapol S: More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep 2021, 11:16144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re&#x2019;em Y, Redfield S, Austin JP, Akrami A: Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 2021,</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Deer RR, Rock MA, Vasilevsky N, Carmody L, Rando H, Anzalone AJ, Basson MD, Bennett TD, Bergquist T, Boudreau EA, et al.: Characterizing Long COVID: Deep Phenotype of a Complex Condition. EBioMedicine 2021, 74:103722.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8613500</ArticleId><ArticleId IdType="pubmed">34839263</ArticleId></ArticleIdList></Reference><Reference><Citation>Estiri H, Strasser ZH, Brat GA, Semenov YR, Consortium for Characterization of COVID-19 by EHR (4CE), Patel CJ, Murphy SN: Evolving phenotypes of non-hospitalized patients that indicate long COVID. BMC Med 2021, 19:249.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8474909</ArticleId><ArticleId IdType="pubmed">34565368</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian, Nirantharakumar: Symptoms and risk factors for long COVID in non-hospitalised adults. Nature [date unknown],</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Sneller MC, Liang CJ, Marques AR, Chung JY, Shanbhag SM, Fontana JR, Raza H, Okeke O, Dewar RL, Higgins BP, et al.: A Longitudinal Study of COVID-19 Sequelae and Immunity: Baseline Findings. Ann Intern Med 2022, doi:10.7326/M21-4905.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M21-4905</ArticleId><ArticleId IdType="pmc">PMC9128805</ArticleId><ArticleId IdType="pubmed">35605238</ArticleId></ArticleIdList></Reference><Reference><Citation>Durstenfeld MS, Peluso MJ, Peyser ND, Lin F, Knight SJ, Djibo A, Khatib R, Kitzman H, O&#x2019;Brien E, Williams N, et al.: Factors Associated With Long COVID Symptoms in an Online Cohort Study. Open Forum Infect Dis 2023, 10:ofad047.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9945931</ArticleId><ArticleId IdType="pubmed">36846611</ArticleId></ArticleIdList></Reference><Reference><Citation>Pujari S, Gaikwad S, Chitalikar A, Dabhade D, Joshi K, Bele V: Long-coronavirus disease among people living with HIV in western India: An observational study. Immun Inflamm Dis 2021, 9:1037&#x2013;1043.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8239760</ArticleId><ArticleId IdType="pubmed">34078004</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzitelli M, Trunfio M, Sasset L, Leoni D, Castelli E, Lo Menzo S, Gardin S, Putaggio C, Brundu M, Garzotto P, et al.: Factors Associated with Severe COVID-19 and Post-Acute COVID-19 Syndrome in a Cohort of People Living with HIV on Antiretroviral Treatment and with Undetectable HIV RNA. Viruses 2022, 14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8954437</ArticleId><ArticleId IdType="pubmed">35336900</ArticleId></ArticleIdList></Reference><Reference><Citation>Kingery JR, Safford MM, Martin P, Lau JD, Rajan M, Wehmeyer GT, Li HA, Alshak MN, Jabri A, Kofman A, et al.: Health Status, Persistent Symptoms, and Effort Intolerance One Year After Acute COVID-19 Infection. J Gen Intern Med 2022, 37:1218&#x2013;1225.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8786200</ArticleId><ArticleId IdType="pubmed">35075531</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Spinelli MA, Deveau T-M, Forman CA, Munter SE, Mathur S, Tang AF, Lu S, Goldberg SA, Arreguin MI, et al.: Postacute sequelae and adaptive immune responses in people with HIV recovering from SARS-COV-2 infection. AIDS 2022, 36:F7&#x2013;F16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9444925</ArticleId><ArticleId IdType="pubmed">35866847</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Deveau T-M, Munter SE, Ryder DM, Buck AM, Beck-Engeser G, Chan F, Lu S, Goldberg SA, Hoh R, et al.: Chronic viral coinfections differentially affect the likelihood of developing long COVID. J Clin Invest 2022, doi:10.1172/JCI163669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI163669</ArticleId><ArticleId IdType="pmc">PMC9888380</ArticleId><ArticleId IdType="pubmed">36454631</ArticleId></ArticleIdList></Reference><Reference><Citation>Yendewa G, Perez JA, Patil N, McComsey GA: HIV Infection is Associated with Higher Risk of Post-Acute Sequelae of SARS-CoV-2 (PASC) However Vaccination is Protective. 2022, doi:10.2139/ssrn.4276609.</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.4276609</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Deeks SG: Early clues regarding the pathogenesis of long-COVID. Trends Immunol 2022, 43:268&#x2013;270.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8901423</ArticleId><ArticleId IdType="pubmed">35272932</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco JL, Ambrosioni J, Garcia F, Mart&#xed;nez E, Soriano A, Mallolas J, Miro JM, COVID-19 in HIV Investigators: COVID-19 in patients with HIV: clinical case series. Lancet HIV 2020, 7:e314&#x2013;e316.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159872</ArticleId><ArticleId IdType="pubmed">32304642</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xe4;rter G, Spinner CD, Roider J, Bickel M, Krznaric I, Grunwald S, Schabaz F, Gillor D, Postel N, Mueller MC, et al.: COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients. Infection 2020, 48:681&#x2013;686.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7211976</ArticleId><ArticleId IdType="pubmed">32394344</ArticleId></ArticleIdList></Reference><Reference><Citation>Vizcarra P, P&#xe9;rez-El&#xed;as MJ, Quereda C, Moreno A, Vivancos MJ, Dronda F, Casado JL, COVID-19 ID Team: Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort. Lancet HIV 2020, 7:e554&#x2013;e564.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7255735</ArticleId><ArticleId IdType="pubmed">32473657</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigel K, Swartz T, Golden E, Paranjpe I, Somani S, Richter F, De Freitas JK, Miotto R, Zhao S, Polak P, et al.: Coronavirus 2019 and People Living With Human Immunodeficiency Virus: Outcomes for Hospitalized Patients in New York City. Clin Infect Dis 2020, 71:2933&#x2013;2938.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7337691</ArticleId><ArticleId IdType="pubmed">32594164</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho H-E, Peluso MJ, Margus C, Matias Lopes JP, He C, Gaisa MM, Osorio G, Aberg JA, Mullen MP: Clinical Outcomes and Immunologic Characteristics of Coronavirus Disease 2019 in People With Human Immunodeficiency Virus. J Infect Dis 2021, 223:403&#x2013;408.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7337732</ArticleId><ArticleId IdType="pubmed">32601704</ArticleId></ArticleIdList></Reference><Reference><Citation>Tesoriero JM, Swain C-AE, Pierce JL, Zamboni L, Wu M, Holtgrave DR, Gonzalez CJ, Udo T, Morne JE, Hart-Malloy R, et al.: COVID-19 Outcomes Among Persons Living With or Without Diagnosed HIV Infection in New York State. JAMA Netw Open 2021, 4:e2037069.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7859843</ArticleId><ArticleId IdType="pubmed">33533933</ArticleId></ArticleIdList></Reference><Reference><Citation>Mellor MM, Bast AC, Jones NR, Roberts NW, Ord&#xf3;&#xf1;ez-Mena JM, Reith AJM, Butler CC, Matthews PC, Dorward J: Risk of adverse coronavirus disease 2019 outcomes for people living with HIV. AIDS 2021, 35:F1&#x2013;F10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7924978</ArticleId><ArticleId IdType="pubmed">33587448</ArticleId></ArticleIdList></Reference><Reference><Citation>Rial-Crestelo D, Bisbal O, Font R, De Lagarde M, Pinto A, Arce-Garc&#xed;a O, Santacreu-Guerrero M, Bermejo-Plaza L, Rubio R, Pulido F: Incidence and severity of SARS-CoV-2 infection in HIV-infected individuals during the first year of the pandemic. J Acquir Immune Defic Syndr 2021, doi:10.1097/QAI.0000000000002896.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QAI.0000000000002896</ArticleId><ArticleId IdType="pubmed">34954717</ArticleId></ArticleIdList></Reference><Reference><Citation>Nomah DK, Reyes-Urue&#xf1;a J, D&#xed;az Y, Moreno S, Aceiton J, Bruguera A, Vivanco-Hidalgo RM, Llibre JM, Domingo P, Falc&#xf3; V, et al.: Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study. Lancet HIV 2021, 8:e701&#x2013;e710.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8514194</ArticleId><ArticleId IdType="pubmed">34655549</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X, Sun J, Patel RC, Zhang J, Guo S, Zheng Q, Olex AL, Olatosi B, Weissman SB, Islam JY, et al.: Associations between HIV infection and clinical spectrum of COVID-19: a population level analysis based on US National COVID Cohort Collaborative (N3C) data. Lancet HIV 2021, 8:e690&#x2013;e700.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8514200</ArticleId><ArticleId IdType="pubmed">34655550</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhaskaran K, Rentsch CT, MacKenna B, Schultze A, Mehrkar A, Bates CJ, Eggo RM, Morton CE, Bacon SCJ, Inglesby P, et al.: HIV infection and COVID-19 death: a population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform. Lancet HIV 2021, 8:e24&#x2013;e32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7773630</ArticleId><ArticleId IdType="pubmed">33316211</ArticleId></ArticleIdList></Reference><Reference><Citation>Geretti AM, Stockdale AJ, Kelly SH, Cevik M, Collins S, Waters L, Villa G, Docherty A, Harrison EM, Turtle L, et al.: Outcomes of Coronavirus Disease 2019 (COVID-19) Related Hospitalization Among People With Human Immunodeficiency Virus (HIV) in the ISARIC World Health Organization (WHO) Clinical Characterization Protocol (UK): A Prospective Observational Study. Clin Infect Dis 2021, 73:e2095&#x2013;e2106.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7665382</ArticleId><ArticleId IdType="pubmed">33095853</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertagnolio S, Thwin S, Silva R, Ford N, Baggaley R, Vitoria M, Jassat W, Doherty M: Clinical characteristics and prognostic factors in people living with HIV hospitalized with COVID-19: findings from the WHO Global Clinical Platform. In 11th International AIDS Society Conference on HIV Science.. 2021:18&#x2013;21.</Citation></Reference><Reference><Citation>Wang H, Jonas KJ: The likelihood of severe COVID-19 outcomes among PLHIV with various comorbidities: a comparative frequentist and Bayesian meta-analysis approach. J Int AIDS Soc 2021, 24:e25841.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8604378</ArticleId><ArticleId IdType="pubmed">34797952</ArticleId></ArticleIdList></Reference><Reference><Citation>Jassat W, Cohen C, Tempia S, Masha M, Goldstein S, Kufa T, Murangandi P, Savulescu D, Walaza S, Bam J-L, et al.: Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort study. Lancet HIV 2021, 8:e554&#x2013;e567.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8336996</ArticleId><ArticleId IdType="pubmed">34363789</ArticleId></ArticleIdList></Reference><Reference><Citation>Madhi SA, Nel J: Epidemiology of severe COVID-19 from South Africa. Lancet HIV 2021, 8:e524&#x2013;e526.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8336967</ArticleId><ArticleId IdType="pubmed">34363788</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann C, Casado JL, H&#xe4;rter G, Vizcarra P, Moreno A, Cattaneo D, Meraviglia P, Spinner CD, Schabaz F, Grunwald S, et al.: Immune deficiency is a risk factor for severe COVID-19 in people living with HIV. HIV Med 2021, 22:372&#x2013;378.</Citation><ArticleIdList><ArticleId IdType="pubmed">33368966</ArticleId></ArticleIdList></Reference><Reference><Citation>Dandachi D, Geiger G, Montgomery MW, Karmen-Tuohy S, Golzy M, Antar AAR, Llibre JM, Camazine M, D&#xed;az-De Santiago A, Carlucci PM, et al.: Characteristics, Comorbidities, and Outcomes in a Multicenter Registry of Patients With Human Immunodeficiency Virus and Coronavirus Disease 2019. Clin Infect Dis 2021, 73:e1964&#x2013;e1972.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7499544</ArticleId><ArticleId IdType="pubmed">32905581</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsue PY, Deeks SG, Hunt PW: Immunologic basis of cardiovascular disease in HIV-infected adults. J Infect Dis 2012, 205 Suppl 3:S375&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3349295</ArticleId><ArticleId IdType="pubmed">22577211</ArticleId></ArticleIdList></Reference><Reference><Citation>Anand AR, Rachel G, Parthasarathy D: HIV Proteins and Endothelial Dysfunction: Implications in Cardiovascular Disease. Front Cardiovasc Med 2018, 5:185.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6305718</ArticleId><ArticleId IdType="pubmed">30619892</ArticleId></ArticleIdList></Reference><Reference><Citation>McLaughlin MM, Ma Y, Scherzer R, Rahalkar S, Martin JN, Mills C, Milush J, Deeks SG, Hsue PY: Association of Viral Persistence and Atherosclerosis in Adults With Treated HIV Infection. JAMA Netw Open 2020, 3:e2018099.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7596582</ArticleId><ArticleId IdType="pubmed">33119103</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu DC, Ma YF, Hur S, Li D, Rupert A, Scherzer R, Kalapus SC, Deeks S, Sereti I, Hsue PY: Plasma IL-6 levels are independently associated with atherosclerosis and mortality in HIV-infected individuals on suppressive antiretroviral therapy. AIDS 2016, 30:2065&#x2013;2074.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5586221</ArticleId><ArticleId IdType="pubmed">27177313</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow FC, Ma Y, Manion M, Rupert A, Lambert-Messerlian G, Bushnell CD, Cedars MI, Sereti I, Sorond FA, Hsue PY, et al.: Factors associated with worse cerebrovascular function in aging women with and at risk for HIV. AIDS 2021, 35:257&#x2013;266.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7789911</ArticleId><ArticleId IdType="pubmed">33229895</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsue PY, Waters DD: HIV infection and coronary heart disease: mechanisms and management. Nat Rev Cardiol 2019, 16:745&#x2013;759.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8015945</ArticleId><ArticleId IdType="pubmed">31182833</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalra S, Kalra B, Agrawal N, Unnikrishnan A: Understanding diabetes in patients with HIV/AIDS. Diabetol Metab Syndr 2011, 3:2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3025836</ArticleId><ArticleId IdType="pubmed">21232158</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez-Romieu AC, Garg S, Rosenberg ES, Thompson-Paul AM, Skarbinski J: Is diabetes prevalence higher among HIV-infected individuals compared with the general population? Evidence from MMP and NHANES 2009&#x2013;2010. BMJ Open Diabetes Res Care 2017, 5:e000304.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5293823</ArticleId><ArticleId IdType="pubmed">28191320</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkar S, Brown TT: Diabetes in People with HIV. Curr Diab Rep 2021, 21:13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8208107</ArticleId><ArticleId IdType="pubmed">33730223</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams C, Zacharia S, Masters L, Coffey C, Catalan P: Mental health problems in people living with HIV: changes in the last two decades: the London experience 1990&#x2013;2014. AIDS Care 2016, 28 Suppl 1:56&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4828597</ArticleId><ArticleId IdType="pubmed">26888472</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook JA, Burke-Miller JK, Steigman PJ, Schwartz RM, Hessol NA, Milam J, Merenstein DJ, Anastos K, Golub ET, Cohen MH: Prevalence, Comorbidity, and Correlates of Psychiatric and Substance Use Disorders and Associations with HIV Risk Behaviors in a Multisite Cohort of Women Living with HIV. AIDS Behav 2018, 22:3141&#x2013;3154.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6153984</ArticleId><ArticleId IdType="pubmed">29460130</ArticleId></ArticleIdList></Reference><Reference><Citation>Lesko CR, Keil AP, Moore RD, Chander G, Fojo AT, Lau B: Measurement of Current Substance Use in a Cohort of HIV-Infected Persons in Continuity HIV Care, 2007&#x2013;2015. Am J Epidemiol 2018, 187:1970&#x2013;1979.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6118067</ArticleId><ArticleId IdType="pubmed">29701832</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghiasvand H, Higgs P, Noroozi M, Ghaedamini Harouni G, Hemmat M, Ahounbar E, Haroni J, Naghdi S, Nazeri Astaneh A, Armoon B: Social and demographical determinants of quality of life in people who live with HIV/AIDS infection: evidence from a meta-analysis. Biodemography Soc Biol 2020, 65:57&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">30882251</ArticleId></ArticleIdList></Reference><Reference><Citation>Farhadian S, Patel P, Spudich S: Neurological Complications of HIV Infection. Curr Infect Dis Rep 2017, 19:50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7456329</ArticleId><ArticleId IdType="pubmed">29164407</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Hellmuth J, Chow FC: Central Nervous System Effects of COVID-19 in People with HIV Infection. Curr HIV/AIDS Rep 2021, doi:10.1007/s11904-021-00582-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11904-021-00582-x</ArticleId><ArticleId IdType="pmc">PMC8628487</ArticleId><ArticleId IdType="pubmed">34843065</ArticleId></ArticleIdList></Reference><Reference><Citation>Hellmuth J, Barnett TA, Asken BM, Kelly JD, Torres L, Stephens ML, Greenhouse B, Martin JN, Chow FC, Deeks SG, et al.: Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patients. J Neurovirol 2021, 27:191&#x2013;195.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7852463</ArticleId><ArticleId IdType="pubmed">33528824</ArticleId></ArticleIdList></Reference><Reference><Citation>Apple AC, Oddi A, Peluso MJ, Asken BM, Henrich TJ, Kelly JD, Pleasure SJ, Deeks SG, Allen IE, Martin JN, et al.: Risk factors and abnormal cerebrospinal fluid associate with cognitive symptoms after mild COVID-19. Ann Clin Transl Neurol 2022, 9:221&#x2013;226.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8862406</ArticleId><ArticleId IdType="pubmed">35043593</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas C, Wong P, Klein J, Castro TBR, Silva J, Sundaram M, Ellingson MK, Mao T, Oh JE, Israelow B, et al.: Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature 2020, 584:463&#x2013;469.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7477538</ArticleId><ArticleId IdType="pubmed">32717743</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonny TS, Patel EU, Zhu X, Bloch EM, Grabowski MK, Abraham AG, Littlefield K, Shrestha R, Benner SE, Laeyendecker O, et al.: Cytokine and Chemokine Levels in Coronavirus Disease 2019 Convalescent Plasma. Open Forum Infect Dis 2021, 8:ofaa574.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7717355</ArticleId><ArticleId IdType="pubmed">33553467</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Lu S, Tang AF, Durstenfeld MS, Ho H-E, Goldberg SA, Forman CA, Munter SE, Hoh R, Tai V, et al.: Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection. J Infect Dis 2021, doi:10.1093/infdis/jiab490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab490</ArticleId><ArticleId IdType="pmc">PMC8643408</ArticleId><ArticleId IdType="pubmed">34677601</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Sans HM, Forman CA, Nylander AN, Ho H-E, Lu S, Goldberg SA, Hoh R, Tai V, Munter SE, et al.: Plasma Markers of Neurologic Injury and Inflammation in People With Self-Reported Neurologic Postacute Sequelae of SARS-CoV-2 Infection. Neurol Neuroimmunol Neuroinflamm 2022, 9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9210548</ArticleId><ArticleId IdType="pubmed">35701186</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB, Howe A, Munier CML, Patel SK, Juno JA, Burrell LM, Kent SJ, Dore GJ, et al.: Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol 2022,</Citation><ArticleIdList><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C, Willscher E, Paschold L, Gottschick C, Klee B, Henkes S-S, Bosurgi L, Dutzmann J, Sedding D, Frese T, et al.: The IL-1&#x3b2;, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19. Cell Rep Med 2022, 3:100663.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9214726</ArticleId><ArticleId IdType="pubmed">35732153</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, Li S, Hong S, Zhang R, Xie J, et al.: Multiple Early Factors Anticipate Post-Acute COVID-19 Sequelae. Cell 2022, 0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J, Wood J, Jaycox J, Lu P, Dhodapkar RM, Gehlhausen JR, Tabachnikova A, Tabacof L, Malik AA, Kamath K, et al.: Distinguishing features of Long COVID identified through immune profiling. medRxiv 2022, doi:10.1101/2022.08.09.22278592.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.08.09.22278592</ArticleId><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayakumar B, Boustani K, Ogger PP, Papadaki A, Tonkin J, Orton CM, Ghai P, Suveizdyte K, Hewitt RJ, Desai SR, et al.: Immuno-proteomic profiling reveals aberrant immune cell regulation in the airways of individuals with ongoing post-COVD-19 respiratory disease. Immunity 2022, 0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8789571</ArticleId><ArticleId IdType="pubmed">35151371</ArticleId></ArticleIdList></Reference><Reference><Citation>Littlefield KM, Watson RO, Schneider JM, Neff CP, Yamada E, Zhang M, Campbell TB, Falta MT, Jolley SE, Fontenot AP, et al.: SARS-CoV-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2. PLoS Pathog 2022, 18:e1010359.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9176759</ArticleId><ArticleId IdType="pubmed">35617421</ArticleId></ArticleIdList></Reference><Reference><Citation>Sollini M, Morbelli S, Ciccarelli M, Cecconi M, Aghemo A, Morelli P, Chiola S, Gelardi F, Chiti A: Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study. Eur J Nucl Med Mol Imaging 2021, 48:3187&#x2013;3197.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7937050</ArticleId><ArticleId IdType="pubmed">33677642</ArticleId></ArticleIdList></Reference><Reference><Citation>Durstenfeld MS, Peluso MJ, Kelly JD, Win S, Swaminathan S, Li D, Arechiga VM, Zepeda V, Sun K, Shao S, et al.: Role of antibodies, inflammatory markers, and echocardiographic findings in postacute cardiopulmonary symptoms after SARS-CoV-2 infection. JCI Insight 2022, 7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9220849</ArticleId><ArticleId IdType="pubmed">35389890</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoury G, Fromentin R, Solomon A, Hartogensis W, Killian M, Hoh R, Somsouk M, Hunt PW, Girling V, Sinclair E, et al.: Human Immunodeficiency Virus Persistence and T-Cell Activation in Blood, Rectal, and Lymph Node Tissue in Human Immunodeficiency Virus-Infected Individuals Receiving Suppressive Antiretroviral Therapy. J Infect Dis 2017, 215:911&#x2013;919.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5407052</ArticleId><ArticleId IdType="pubmed">28453847</ArticleId></ArticleIdList></Reference><Reference><Citation>Somsouk M, Estes JD, Deleage C, Dunham RM, Albright R, Inadomi JM, Martin JN, Deeks SG, McCune JM, Hunt PW: Gut epithelial barrier and systemic inflammation during chronic HIV infection. AIDS 2015, 29:43&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4444362</ArticleId><ArticleId IdType="pubmed">25387317</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenorio AR, Zheng Y, Bosch RJ, Krishnan S, Rodriguez B, Hunt PW, Plants J, Seth A, Wilson CC, Deeks SG, et al.: Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment. J Infect Dis 2014, 210:1248&#x2013;1259.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4192039</ArticleId><ArticleId IdType="pubmed">24795473</ArticleId></ArticleIdList></Reference><Reference><Citation>Serrano-Villar S, Sainz T, Lee SA, Hunt PW, Sinclair E, Shacklett BL, Ferre AL, Hayes TL, Somsouk M, Hsue PY, et al.: HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality. PLoS Pathog 2014, 10:e1004078.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4022662</ArticleId><ArticleId IdType="pubmed">24831517</ArticleId></ArticleIdList></Reference><Reference><Citation>Borges &#xc1;H, O&#x2019;Connor JL, Phillips AN, R&#xf6;nsholt FF, Pett S, Vjecha MJ, French MA, Lundgren JD, INSIGHT SMART and ESPRIT Study Groups and the SILCAAT Scientific Committee: Factors Associated With Plasma IL-6 Levels During HIV Infection. J Infect Dis 2015, 212:585&#x2013;595.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4598808</ArticleId><ArticleId IdType="pubmed">25722296</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C, Wang Z, Lorenzi JCC, Muecksch F, Finkin S, Tokuyama M, Cho A, Jankovic M, Schaefer-Babajew D, Oliveira TY, et al.: Evolution of antibody immunity to SARS-CoV-2. Nature 2021, doi:10.1038/s41586-021-03207-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03207-w</ArticleId><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Natarajan A, Zlitni S, Brooks EF, Vance SE, Dahlen A, Hedlin H, Park RM, Han A, Schmidtke DT, Verma R, et al.: Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection. Med (N Y) 2022, doi:10.1016/j.medj.2022.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medj.2022.04.001</ArticleId><ArticleId IdType="pmc">PMC9005383</ArticleId><ArticleId IdType="pubmed">35434682</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Deeks SG, Mustapic M, Kapogiannis D, Henrich TJ, Lu S, Goldberg SA, Hoh R, Chen JY, Martinez EO, et al.: SARS-CoV-2 and Mitochondrial Proteins in Neural-Derived Exosomes of COVID-19. Ann Neurol 2022, doi:10.1002/ana.26350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26350</ArticleId><ArticleId IdType="pmc">PMC9082480</ArticleId><ArticleId IdType="pubmed">35285072</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank Z, Senussi Y, Manickas-Hill Z, Yu XG, Li JZ, Alter G, Walt DR: Persistent circulating SARS-CoV-2 spike is associated with post-acute COVID-19 sequelae. Clin Infect Dis 2022, doi:10.1093/cid/ciac722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac722</ArticleId><ArticleId IdType="pmc">PMC10169416</ArticleId><ArticleId IdType="pubmed">36052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Craddock V, Mahajan A, Krishnamachary B, Spikes L, Chalise P, Dhillon NK: Persistent presence of Spike protein and viral RNA in the circulation of individuals with post-acute sequelae of COVID-19. bioRxiv 2022, doi:10.1101/2022.08.07.22278520.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.08.07.22278520</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Deitchman AN, Torres L, Iyer NS, Munter SE, Nixon CC, Donatelli J, Thanh C, Takahashi S, Hakim J, et al.: Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms. Cell Rep 2021,</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8342976</ArticleId><ArticleId IdType="pubmed">34358460</ArticleId></ArticleIdList></Reference><Reference><Citation>Herman JD, Atyeo C, Zur Y, Cook CE, Patel NJ, Vanni KM, Kowalski EN, Qian G, Shadick NA, Laffenburger D, et al.: Impact of cross-coronavirus immunity in post-acute sequelae of COVID-19. medRxiv 2022, doi:10.1101/2022.09.25.22280335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.09.25.22280335</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu F, Chen F, Ou Z, Fan Q, Tan X, Wang Y, Pan Y, Ke B, Li L, Guan Y, et al.: A compromised specific humoral immune response against the SARS-CoV-2 receptor-binding domain is related to viral persistence and periodic shedding in the gastrointestinal tract. Cell Mol Immunol 2020, 17:1119&#x2013;1125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7546387</ArticleId><ArticleId IdType="pubmed">33037400</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Casta&#xf1;eda A, Lu P, Geraghty AC, Song E, Lee M-H, Wood J, Yal&#xe7;&#x131;n B, Taylor KR, Dutton S, Acosta-Alvarez L, et al.: Mild respiratory SARS-CoV-2 infection can cause multi-lineage cellular dysregulation and myelin loss in the brain. bioRxiv 2022, doi:10.1101/2022.01.07.475453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.01.07.475453</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergamaschi L, Mescia F, Turner L, Hanson AL, Kotagiri P, Dunmore BJ, Ruffieux H, De Sa A, Huhn O, Morgan MD, et al.: Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease. Immunity 2021, 54:1257&#x2013;1275.e8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8125900</ArticleId><ArticleId IdType="pubmed">34051148</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervia C, Zurbuchen Y, Taeschler P, Ballouz T, Menges D, Hasler S, Adamo S, Raeber ME, B&#xe4;chli E, Rudiger A, et al.: Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome. Nat Commun 2022, 13:446.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8789854</ArticleId><ArticleId IdType="pubmed">35078982</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia X, Cao S, Lee AS, Manohar M, Sindher SB, Ahuja N, Artandi M, Blish CA, Blomkalns AL, Chang I, et al.: Anti-nucleocapsid antibody levels and pulmonary comorbid conditions are linked to post&#x2013;COVID-19 syndrome. JCI Insight 7 2022, 7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9310538</ArticleId><ArticleId IdType="pubmed">35801588</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinelli MA, Lynch KL, Yun C, Glidden DV, Peluso MJ, Henrich TJ, Gandhi M, Brown LB: SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study. Lancet HIV 2021, 8:e334&#x2013;e341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8084354</ArticleId><ArticleId IdType="pubmed">33933189</ArticleId></ArticleIdList></Reference><Reference><Citation>Verburgh ML, Boyd A, Wit FWNM, Schim van der Loeff MF, van der Valk M, Bakker M, Kootstra NA, van der Hoek L, Reiss P, AGEhIV Study Group: Similar risk of SARS-CoV-2 infection and similar nucleocapsid antibody levels in people with well-controlled HIV and a comparable cohort of people without HIV. J Infect Dis 2021, doi:10.1093/infdis/jiab616.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab616</ArticleId><ArticleId IdType="pmc">PMC8755357</ArticleId><ArticleId IdType="pubmed">34929034</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;n-Vicente M, Berenguer J, Mu&#xf1;oz-G&#xf3;mez MJ, D&#xed;ez C, Mic&#xe1;n R, P&#xe9;rez-El&#xed;as MJ, Garc&#xed;a-Fraile LJ, Peraire J, Su&#xe1;rez-Garc&#xed;a I, Jim&#xe9;nez-Sousa M&#xc1;, et al.: Similar humoral immune responses against the SARS-CoV-2 spike protein in HIV and non-HIV individuals after COVID-19. J Infect 2021, doi:10.1016/j.jinf.2021.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.11.002</ArticleId><ArticleId IdType="pmc">PMC8574204</ArticleId><ArticleId IdType="pubmed">34752819</ArticleId></ArticleIdList></Reference><Reference><Citation>Snyman J, Hwa S-H, Krause R, Muema D, Reddy T, Ganga Y, Karim F, Leslie A, Sigal A, Ndung&#x2019;u T, et al.: Similar antibody responses against SARS-CoV-2 in HIV uninfected and infected individuals on antiretroviral therapy during the first South African infection wave. Clin Infect Dis 2021, doi:10.1093/cid/ciab758.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab758</ArticleId><ArticleId IdType="pmc">PMC8522359</ArticleId><ArticleId IdType="pubmed">34472583</ArticleId></ArticleIdList></Reference><Reference><Citation>Alrubayyi A, Gea-Mallorqu&#xed; E, Touizer E, Hameiri-Bowen D, Kopycinski J, Charlton B, Fisher-Pearson N, Muir L, Rosa A, Roustan C, et al.: Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV. Nat Commun 2021, 12:5839.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8492866</ArticleId><ArticleId IdType="pubmed">34611163</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahamed J, Laurence J: Long COVID endotheliopathy: hypothesized mechanisms and potential therapeutic approaches. J Clin Invest 2022, 132.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9337829</ArticleId><ArticleId IdType="pubmed">35912863</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Venter C, Laubscher GJ, Kotze MJ, Oladejo SO, Watson LR, Rajaratnam K, Watson BW, Kell DB: Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC). Cardiovasc Diabetol 2022, 21:148.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9356426</ArticleId><ArticleId IdType="pubmed">35933347</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Vlok M, Venter C, Bezuidenhout JA, Laubscher GJ, Steenkamp J, Kell DB: Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc Diabetol 2021, 20:172.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty H, Townsend L, Morrin H, Ahmad A, Comerford C, Karampini E, Englert H, Byrne M, Bergin C, O&#x2019;Sullivan JM, et al.: Persistent endotheliopathy in the pathogenesis of long COVID syndrome. J Thromb Haemost 2021, 19:2546&#x2013;2553.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8420256</ArticleId><ArticleId IdType="pubmed">34375505</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun B, Tang N, Peluso MJ, Iyer NS, Torres L, Donatelli JL, Munter SE, Nixon CC, Rutishauser RL, Rodriguez-Barraquer I, et al.: Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological Manifestations. Cells 2021, 10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7918597</ArticleId><ArticleId IdType="pubmed">33668514</ArticleId></ArticleIdList></Reference><Reference><Citation>Giron LB, Peluso MJ, Ding J, Kenny G, Zilberstein NF, Koshy J, Hong KY, Rasmussen H, Miller GE, Bishehsari F, et al.: Markers of fungal translocation are elevated during post-acute sequelae of SARS-CoV-2 and induce NF-&#x3ba;B signaling. JCI Insight 2022, 7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9462470</ArticleId><ArticleId IdType="pubmed">35727635</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeoh YK, Zuo T, Lui GC-Y, Zhang F, Liu Q, Li AY, Chung AC, Cheung CP, Tso EY, Fung KS, et al.: Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut 2021, 70:698&#x2013;706.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7804842</ArticleId><ArticleId IdType="pubmed">33431578</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T, Zhang F, Lui GCY, Yeoh YK, Li AYL, Zhan H, Wan Y, Chung ACK, Cheung CP, Chen N, et al.: Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization. Gastroenterology 2020, 159:944&#x2013;955.e8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7237927</ArticleId><ArticleId IdType="pubmed">32442562</ArticleId></ArticleIdList></Reference><Reference><Citation>Haran JP, Bradley E, Zeamer AL, Cincotta L, Salive M-C, Dutta P, Mutaawe S, Anya O, Meza-Segura M, Moormann AM, et al.: Inflammation-type dysbiosis of the oral microbiome associates with the duration of COVID-19 symptoms and long COVID. JCI Insight 2021, 6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8564890</ArticleId><ArticleId IdType="pubmed">34403368</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, Su Q, Zhang F, Tun HM, Mak JWY, Lui GC-Y, Ng SSS, Ching JYL, Li A, Lu W, et al.: Multi-kingdom gut microbiota analyses define COVID-19 severity and post-acute COVID-19 syndrome. Nat Commun 2022, 13:6806.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9648868</ArticleId><ArticleId IdType="pubmed">36357381</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, Mak JWY, Su Q, Yeoh YK, Lui GC-Y, Ng SSS, Zhang F, Li AYL, Lu W, Hui DS-C, et al.: Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut 2022, 71:544&#x2013;552.</Citation><ArticleIdList><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>Zevin AS, McKinnon L, Burgener A, Klatt NR: Microbial translocation and microbiome dysbiosis in HIV-associated immune activation. Curr Opin HIV AIDS 2016, 11:182&#x2013;190.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4752849</ArticleId><ArticleId IdType="pubmed">26679414</ArticleId></ArticleIdList></Reference><Reference><Citation>Iordache L, Launay O, Bouchaud O, Jeantils V, Goujard C, Boue F, Cacoub P, Hanslik T, Mahr A, Lambotte O, et al.: Autoimmune diseases in HIV-infected patients: 52 cases and literature review. Autoimmun Rev 2014, 13:850&#x2013;857.</Citation><ArticleIdList><ArticleId IdType="pubmed">24747058</ArticleId></ArticleIdList></Reference><Reference><Citation>Virot E, Duclos A, Adelaide L, Miailhes P, Hot A, Ferry T, Seve P: Autoimmune diseases and HIV infection: A cross-sectional study. Medicine 2017, 96:e5769.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5287948</ArticleId><ArticleId IdType="pubmed">28121924</ArticleId></ArticleIdList></Reference><Reference><Citation>Yen Y-F, Chuang P-H, Jen I-A, Chen M, Lan Y-C, Liu Y-L, Lee Y, Chen Y-H, Chen Y-MA: Incidence of autoimmune diseases in a nationwide HIV/AIDS patient cohort in Taiwan, 2000&#x2013;2012. Ann Rheum Dis 2017, 76:661&#x2013;665.</Citation><ArticleIdList><ArticleId IdType="pubmed">27590658</ArticleId></ArticleIdList></Reference><Reference><Citation>Song E, Bartley CM, Chow RD, Ngo TT, Jiang R, Zamecnik CR, Dandekar R, Loudermilk RP, Dai Y, Liu F, et al.: Divergent and self-reactive immune responses in the CNS of COVID-19 patients with neurological symptoms. Cell Rep Med 2021, 2:100288.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8091032</ArticleId><ArticleId IdType="pubmed">33969321</ArticleId></ArticleIdList></Reference><Reference><Citation>See&#xdf;le J, Waterboer T, Hippchen T, Simon J, Kirchner M, Lim A, M&#xfc;ller B, Merle U: Persistent symptoms in adult patients one year after COVID-19: a prospective cohort study. Clin Infect Dis 2021, doi:10.1093/cid/ciab611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab611</ArticleId><ArticleId IdType="pmc">PMC8394862</ArticleId><ArticleId IdType="pubmed">34223884</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodruff MC, Ramonell RP, Haddad NS, Anam FA, Rudolph ME, Walker TA, Truong AD, Dixit AN, Han JE, Cabrera-Mora M, et al.: Dysregulated na&#xef;ve B cells and de novo autoreactivity in severe COVID-19. Nature 2022, doi:10.1038/s41586-022-05273-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05273-0</ArticleId><ArticleId IdType="pmc">PMC9630115</ArticleId><ArticleId IdType="pubmed">36044993</ArticleId></ArticleIdList></Reference><Reference><Citation>Son K, Jamil R, Chowdhury A, Mukherjee M, Venegas C, Miyasaki K, Zhang K, Patel Z, Salter B, Yuen ACY, et al.: Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long-COVID symptoms. Eur Respir J 2022, doi:10.1183/13993003.00970-2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00970-2022</ArticleId><ArticleId IdType="pmc">PMC9515477</ArticleId><ArticleId IdType="pubmed">36137590</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang SE, Feng A, Meng W, Apostolidis SA, Mack E, Artandi M, Barman L, Bennett K, Chakraborty S, Chang I, et al.: New-onset IgG autoantibodies in hospitalized patients with COVID-19. Nat Commun 2021, 12:5417.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8440763</ArticleId><ArticleId IdType="pubmed">34521836</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Thomas IJ, Munter SE, Deeks SG, Henrich TJ: Lack of Antinuclear Antibodies in Convalescent Coronavirus Disease 2019 Patients With Persistent Symptoms. Clin Infect Dis 2022, 74:2083&#x2013;2084.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9187313</ArticleId><ArticleId IdType="pubmed">34617982</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Mitchell A, Wang CY, Takahashi S, Hoh R, Tai V, Durstenfeld MS, Hsue PY, Kelly JD, Martin JN, et al.: Low Prevalence of Interferon-&#x3b1; Autoantibodies in People Experiencing Long COVID Symptoms. J Infect Dis 2022, doi:10.1093/infdis/jiac372.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac372</ArticleId><ArticleId IdType="pmc">PMC9494362</ArticleId><ArticleId IdType="pubmed">36089700</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Y, Ren Y, Chen R, Hu J, Ji Y, Yang J, Shen J, Hu L, Pei H, Wang J, et al.: Evaluation of Epstein-Barr Virus Salivary Shedding in HIV/AIDS Patients and HAART Use: A Retrospective Cohort Study. Virol Sin 2018, 33:227&#x2013;233.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6178557</ArticleId><ArticleId IdType="pubmed">29654554</ArticleId></ArticleIdList></Reference><Reference><Citation>Hern&#xe1;ndez DM, Valderrama S, Gualtero S, Hern&#xe1;ndez C, L&#xf3;pez M, Herrera MV, Solano J, Fiorentino S, Quijano S: Loss of T-Cell Multifunctionality and TCR-V&#x3b2; Repertoire Against Epstein-Barr Virus Is Associated With Worse Prognosis and Clinical Parameters in HIV+ Patients. Front Immunol 2018, 9:2291.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6180205</ArticleId><ArticleId IdType="pubmed">30337929</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuhair M, Smit GSA, Wallis G, Jabbar F, Smith C, Devleesschauwer B, Griffiths P: Estimation of the worldwide seroprevalence of cytomegalovirus: A systematic review and meta-analysis. Rev Med Virol 2019, 29:e2034.</Citation><ArticleIdList><ArticleId IdType="pubmed">30706584</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold JE, Okyay RA, Licht WE, Hurley DJ: Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation. Pathogens 2021, 10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8233978</ArticleId><ArticleId IdType="pubmed">34204243</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Bakkour S, Busch MP, Deeks SG, Henrich TJ: A High Percentage of People With Human Immunodeficiency Virus (HIV) on Antiretroviral Therapy Experience Detectable Low-Level Plasma HIV-1 RNA Following Coronavirus Disease 2019 (COVID-19). Clin Infect Dis 2021, 73:e2845&#x2013;e2846.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7717237</ArticleId><ArticleId IdType="pubmed">33211091</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul T, Ledderose S, Bartsch H, Sun N, Soliman S, M&#xe4;rkl B, Ruf V, Herms J, Stern M, Keppler OT, et al.: Adrenal tropism of SARS-CoV-2 and adrenal findings in a post-mortem case series of patients with severe fatal COVID-19. Nat Commun 2022, 13:1589.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8948269</ArticleId><ArticleId IdType="pubmed">35332140</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanczkowski W, Evert K, Stadtm&#xfc;ller M, Haberecker M, Laks L, Chen L-S, Frontzek K, Pablik J, Hantel C, Beuschlein F, et al.: COVID-19 targets human adrenal glands. Lancet Diabetes Endocrinol 2022, 10:13&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8601687</ArticleId><ArticleId IdType="pubmed">34801110</ArticleId></ArticleIdList></Reference><Reference><Citation>Henry M, Thomas KGF, Ross IL: Sleep, Cognition and Cortisol in Addison&#x2019;s Disease: A Mechanistic Relationship. Front Endocrinol 2021, 12:694046.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8429905</ArticleId><ArticleId IdType="pubmed">34512546</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayo J, Collazos J, Mart&#xed;nez E, Ibarra S: Adrenal function in the human immunodeficiency virus-infected patient. Arch Intern Med 2002, 162:1095&#x2013;1098.</Citation><ArticleIdList><ArticleId IdType="pubmed">12020177</ArticleId></ArticleIdList></Reference><Reference><Citation>Mifsud S, Gauci Z, Gruppetta M, Mallia Azzopardi C, Fava S: Adrenal insufficiency in HIV/AIDS: a review. Expert Rev Endocrinol Metab 2021, 16:351&#x2013;362.</Citation><ArticleIdList><ArticleId IdType="pubmed">34521306</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC: Post-COVID conditions: Information for healthcare providers. Centers for Disease Control and Prevention 2022,</Citation></Reference><Reference><Citation>Greenhalgh T, Sivan M, Delaney B, Evans R, Milne R: Long covid&#x2014;an update for primary care. BMJ 2022, 378.</Citation><ArticleIdList><ArticleId IdType="pubmed">36137612</ArticleId></ArticleIdList></Reference><Reference><Citation>Santhosh L, Block B, Kim SY, Raju S, Shah RJ, Thakur N, Brigham EP, Parker AM: Rapid Design and Implementation of Post-COVID-19 Clinics. Chest 2021, 160:671&#x2013;677.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8010340</ArticleId><ArticleId IdType="pubmed">33811910</ArticleId></ArticleIdList></Reference><Reference><Citation>Geter A, Herron AR, Sutton MY: HIV-Related Stigma by Healthcare Providers in the United States: A Systematic Review. AIDS Patient Care STDS 2018, 32:418&#x2013;424.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6410696</ArticleId><ArticleId IdType="pubmed">30277814</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma PHX, Chan ZCY, Loke AY: Self-Stigma Reduction Interventions for People Living with HIV/AIDS and Their Families: A Systematic Review. AIDS Behav 2019, 23:707&#x2013;741.</Citation><ArticleIdList><ArticleId IdType="pubmed">30298241</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne EA: Understanding Long Covid: Nosology, social attitudes and stigma. Brain Behav Immun 2022, 99:17&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">34563621</ArticleId></ArticleIdList></Reference><Reference><Citation>Macpherson K, Cooper K, Harbour J, Mahal D, Miller C, Nairn M: Experiences of living with long COVID and of accessing healthcare services: a qualitative systematic review. BMJ Open 2022, 12:e050979.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8753091</ArticleId><ArticleId IdType="pubmed">35017239</ArticleId></ArticleIdList></Reference><Reference><Citation>Santiago-Rodriguez EI, Maiorana A, Peluso MJ, Hoh R, Tai V, Fehrman EA, Hernandez Y, Torres L, Spinelli MA, Gandhi M, et al.: Characterizing the COVID-19 Illness Experience to Inform the Study of Post-acute Sequelae and Recovery. Int J Behav Med 2022, 29:610&#x2013;623.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8675303</ArticleId><ArticleId IdType="pubmed">34918211</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>